• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STIMWAVE TECHNOLOGIES INC. STIMQ NEUROSTIMULATOR; PERIPHERAL NERVE STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STIMWAVE TECHNOLOGIES INC. STIMQ NEUROSTIMULATOR; PERIPHERAL NERVE STIMULATOR Back to Search Results
Model Number STQ4-SPR-B0, STQ4-RCV-A0
Device Problem Material Erosion (1214)
Patient Problems Skin Erosion (2075); Skin Infection (4544)
Event Date 03/11/2021
Event Type  Injury  
Manufacturer Narrative
The implant clinician prescribed antibiotics (name, frequency, dosage unknown) to control the infection and cleaned the area with antibiotic solution.The implanting clinician mentioned to the clinical representative that the patient has multiple conditions that may have contributed to the infection since the patient has type 2 diabetes and a hernia, which may have contributed to the erosion and the infection by pushing the leads the surface of the skin.A stimwave representative conducted a review of sterilization and packaging records for the respective product lot; stimwave has confirmed that the product was delivered sterile, validated sterilization parameters were used, and sterile barriers were verified to be intact following packaging.Based on this information, the infection/erosion was confirmed/replicated.There is no evidence that the product did not meet specifications, and the stimulator is used for the treatment of pain.The cause of the infection/erosion is due to preexisting patient conditions and the stimulator being placed at an off-label location.Design fmea for stimq 06-01233 and hra for stimq 06-01232 was reviewed and infection/erosion are known issue with mitigation controls in place to reduce risk as far as possible and no corrective action is required.Stimwave's global device erosion rate: (b)(4).Stimwave's global infection rate: (b)(4).The frequency is occasionally and the impact is important.
 
Event Description
The stimulator was implanted on the intercostal area.On (b)(6) 2021, the patient went to a follow-up appointment with the implanting clinician who noticed the stimulator was eroding and successfully performed an explant procedure on the same date.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STIMQ NEUROSTIMULATOR
Type of Device
PERIPHERAL NERVE STIMULATOR
Manufacturer (Section D)
STIMWAVE TECHNOLOGIES INC.
1310 park central boulevard s.
pompano beach FL 33064
Manufacturer (Section G)
STIMWAVE TECHNOLOGIES INC.
1310 park central boulevard s.
pompano beach FL 33064
Manufacturer Contact
andrea najera
1310 park central boulevard s.
pompano beach, FL 33064
8009655134
MDR Report Key11646564
MDR Text Key245988008
Report Number3010676138-2021-00066
Device Sequence Number1
Product Code GZF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K171366
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other
Type of Report Initial
Report Date 03/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/10/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date06/01/2021
Device Model NumberSTQ4-SPR-B0, STQ4-RCV-A0
Device Lot NumberSWO190614, SWO191025
Was Device Available for Evaluation? No
Date Manufacturer Received03/11/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-